• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, January 20, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

One-year kidney allograft outcomes do not differ by hepatitis C status of donor

Bioengineer by Bioengineer
December 14, 2020
in Immunology
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: AJKD, 2020

Study published in the American Journal of Kidney Diseases (AJKD) shows that kidney allograft outcomes one year post-transplantation in hepatitis C virus (HCV)-negative recipients do not differ by the HCV status of the donor.

Transplant centers are increasingly willing to transplant kidneys from hepatitis C (HCV)-infected donors to HCV-negative recipients. Data on the long-term outcomes following these recipients are sparse. The aim of this single-center, retrospective study was to compare 1-year kidney outcomes in HCV-negative transplant recipients who received an organ either from a donor with or without HCV infection. The 1-year post-transplant kidney outcomes (including allograft function, development of de novo donor specific antibodies, findings on for-cause and surveillance protocol graft biopsies) were similar in these two groups of recipients.

###

ARTICLE TITLE: Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes

AUTHORS: Miklos Z. Molnar, MD, PhD, Ambreen Azhar, MD, Makoto Tsujita, MD, PhD, Manish Talwar, MD, Vasanthi Balaraman, MD, Anshul Bhalla, MD, Pradeep S.B. Podila, PhD, MS, Jiten Kothadia, MD, Uchenna A. Agbim, MD, MPH, Benedict Maliakkal, MD, Sanjaya K. Satapathy, MD, MS, Csaba P Kovesdy, MD, Satheesh Nair, MD, and James D. Eason, MD

DOI: 10.1053/j.ajkd.2020.10.017

Full text of article available by email from media contact.

Media Contact
Julie Kimbrough
[email protected]

Related Journal Article

http://dx.doi.org/10.1053/j.ajkd.2020.10.017

Tags: EpidemiologyHealth CareHealth Care Systems/ServicesHealth ProfessionalsInfectious/Emerging DiseasesInternal MedicineMedicine/HealthPublic HealthSurgeryTransplantation
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Heart attack patients in England ‘fearful’ of seeking medical help amid COVID crisis

January 19, 2021
IMAGE

5G doesn’t cause COVID-19, but the rumor it does spread like a virus

January 19, 2021

Research establishes antibiotic potential for cannabis molecule

January 19, 2021

Where COVID-19 hit hardest, sudden deaths outside the hospital increased

January 18, 2021
Next Post
IMAGE

High-brightness source of coherent light spanning from the UV to THz

IMAGE

CDC awards Huntsman Cancer Institute $3 million to increase colorectal cancer screening

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    60 shares
    Share 24 Tweet 15
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

GeneticsChemistry/Physics/Materials SciencesMedicine/HealthCell BiologyClimate ChangePublic HealthcancerBiologyTechnology/Engineering/Computer ScienceEcology/EnvironmentInfectious/Emerging DiseasesMaterials

Recent Posts

  • Breakthrough in understanding ‘tummy bug’ bacteria
  • Stealing the spotlight in the field and kitchen
  • Genome editing to treat human retinal degeneration
  • Do simulations represent the real world at the atomic scale?
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In